Trails Edge Capital Partners, LP → Research Alliance Corporation IV RACD

Stake: — Shares: — Class: Class A Ordinary Shares, $0.0001 par value per share

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 6/100

Passive Schedule 13G filer baseline

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

167 shares short · -93.0% vs prior

Other 13D/G Filings on Research Alliance Corporation IV

Filed	Form	Filer	Stake	Shares
2026-07-21	SCHEDULE 13D	Research Alliance Holdings IV LLC	—	1,538,529	view →
2026-07-20	SCHEDULE 13G	BIOTECHNOLOGY VALUE FUND L P	—	—	view →
2026-07-20	SCHEDULE 13G	Commodore Capital LP	—	—	view →
2026-07-20	SCHEDULE 13G	PERCEPTIVE ADVISORS LLC	—	—	view →

Other Filings by Trails Edge Capital Partners, LP

Filed	Form	Issuer	Stake	Shares
2026-10-22	SCHEDULE 13G	Contineum Therapeutics, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →